Detalhe da pesquisa
1.
Health democracy in Europe: Cancer patient organization participation in health policy.
Health Expect
; 21(2): 474-484, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29094422
2.
Variation in Health Technology Assessment and Reimbursement Processes in Europe.
Value Health
; 20(1): 67-76, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28212972
3.
Personalized medicine in Europe: not yet personal enough?
BMC Health Serv Res
; 17(1): 289, 2017 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28424057
4.
[Determinants of the cost of initiation of insulin therapy type 2 diabetic patients in France: possible approaches to optimization]. / Déterminants des coûts du passage à linsuline en France chez le patient diabétique de type 2 : quelles pistes doptimisation ?
Sante Publique
; 28(6): 781-789, 2016 Dec 19.
Artigo
em Francês
| MEDLINE | ID: mdl-28155773
5.
Challenges in the implementation of trastuzumab biosimilars: an expert panel's recommendations.
Anticancer Drugs
; 26(10): 1009-16, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26352219
6.
Web-based analysis of adherence to influenza vaccination among French healthcare workers.
J Clin Virol
; 116: 29-33, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31082729
7.
Cancer patients' organisation participation in heath policy decision-making: a snapshot/cluster analysis of the EU-28 countries.
BMJ Open
; 8(8): e018896, 2018 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30082339
8.
Assessing Patient Organization Participation in Health Policy: A Comparative Study in France and Italy.
Int J Health Policy Manag
; 7(1): 48-58, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29325402